Még nem toboroz
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
NCT07725484· 3. fázis· Shanghai Zhongshan Hospital· Forrás
Contact: Cheng Shen
Toboroz
A Clinical Study to Evaluate the Efficacy and Safety of JS212 Monotherapy or Combination Therapy in Recurrent or Metastatic Triple-negative Breast Cancer(TNBC)
NCT07876557· 2. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Contact: Changping Shan, Master
Még nem toboroz
A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension
NCT07833098· 2. fázis· Zhejiang Yangli Pharmaceutical Technology Co., Ltd.· Forrás
Contact: Yuchuan Dai
Toboroz
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
NCT07614152· 3. fázis· Xiamen Amoytop Biotech Co., Ltd.· Forrás
Contact: Mei Zhang
Toboroz
Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)
NCT07587099· Gan Lijun· Forrás
Contact: Lijun Gan
Toboroz
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NCT07464587· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Bo Jiang, Master
Toboroz
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849· 3. fázis· Incyte Corporation· Forrás
Még nem toboroz
A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
NCT07483684· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Junye Wang, Bachelor
Toboroz
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
NCT07256236· 2. fázis· Fujian Cancer Hospital· Forrás
Contact: Zhu Qiao
Toboroz
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
NCT07176650· 1. fázis· Shanghai Henlius Biotech· Forrás
Contact: Henlius
Fut, nem toboroz
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
NCT07162883· 3. fázis· Qilu Pharmaceutical Co., Ltd.· Forrás
Még nem toboroz
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NCT07147946· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Bo Jiang, Master
Toboroz
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07043400· 3. fázis· BeOne Medicines· Forrás
Contact: BeOne Medicines
Meghívásos bevonás
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
NCT07376629· 2. fázis· Huabo Biopharm Co., Ltd.· Forrás
Toboroz
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer
NCT07008976· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Changping Shan, Bachelor
Toboroz
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06340568· 3. fázis· BioNTech SE· Forrás
Fut, nem toboroz
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors
NCT06970743· 3. fázis· BeOne Medicines· Forrás
Toboroz
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
NCT06644781· 3. fázis· Daiichi Sankyo· Forrás
Még nem toboroz
Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
NCT06861426· Ying Gao· Forrás
Contact: Daojing Li
Toboroz
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
NCT06792552· 1. fázis· NextCure, Inc.· Forrás
Contact: Xiaowei Liu
Toboroz
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
NCT06736574· 3. fázis· Cytokinetics· Forrás
Contact: Cytokinetics MD
Fut, nem toboroz
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
NCT06616532· 3. fázis· Biotheus Inc.· Forrás
Még nem toboroz
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
NCT06606509· Nanjing First Hospital, Nanjing Medical University· Forrás
Contact: Mei Zhang, Doctor
Toboroz
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
NCT06413654· 2/3. fázis· Shanghai Jiaolian Drug Research and Development Co., Ltd· Forrás
Contact: Yuzhong Wang
Még nem toboroz
Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
NCT06475599· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Xiaowei Liu, Bachelor
Fut, nem toboroz
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
NCT06419621· 3. fázis· Biotheus Inc.· Forrás
Toboroz
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
NCT06361888· 2/3. fázis· Hutchmed· Forrás
Contact: Junye Wang
Toboroz
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
NCT06365502· Harbin Medical University· Forrás
Contact: Lijun Gan
Fut, nem toboroz
A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer
NCT06984588· 2/3. fázis· TJ Biopharma Co., Ltd.· Forrás
Toboroz
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
NCT06112704· 2. fázis· Hansoh BioMedical R&D Company· Forrás
Contact: Yun Sun
Toboroz
A Study of YL202 in Selected Patients With Advanced Solid Tumors
NCT06107686· 2. fázis· MediLink Therapeutics (Suzhou) Co., Ltd.· Forrás
Contact: Coordinator Clinical operation director
Toboroz
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
NCT06079983· 3. fázis· Jiangsu Alphamab Biopharmaceuticals Co., Ltd· Forrás
Contact: Changping Shan
Toboroz
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
NCT06095583· 3. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Contact: Shucheng Ye
Toboroz
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NCT05866029· Peking Union Medical College Hospital· Forrás
Contact: Bo Ban
Még nem toboroz
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
NCT05767892· 3. fázis· Suzhou Puhe Pharmaceutical Technology Co., LTD· Forrás
Contact: Shuchen Ye
Fut, nem toboroz
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
NCT06295679· Amgen· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
NCT05503264· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
NCT05365178· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Toboroz
Multicenter Prospective Cohort of Sepsis and ARDS in China
NCT07863908· Shanghai Zhongshan Hospital· Forrás
Contact: Yong Li, MD
Fut, nem toboroz
PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer
NCT05180734· 3. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Toboroz
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
NCT05150691· 1/2. fázis· DualityBio Inc.· Forrás
Contact: Britney Winterberger
Toboroz
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
NCT05851014· 3. fázis· Genor Biopharma Co., Ltd.· Forrás
Contact: Changping Shan, Master
Fut, nem toboroz
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases
NCT04603807· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)
NCT05058040· 4. fázis· Green Valley (Shanghai) Pharmaceuticals Co., Ltd.· Forrás
Fut, nem toboroz
A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
NCT04854668· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Fut, nem toboroz
Optimal Ablation Strategies for Persistent AF With HF
NCT07153718· Xu Liu· Forrás
Fut, nem toboroz
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
NCT04194775· 3. fázis· CStone Pharmaceuticals· Forrás